<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetol Metab Syndr</journal-id><journal-id journal-id-type="iso-abbrev">Diabetol Metab Syndr</journal-id><journal-title-group><journal-title>Diabetology &#x00026; Metabolic Syndrome</journal-title></journal-title-group><issn pub-type="epub">1758-5996</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28828040</article-id><article-id pub-id-type="pmc">5563031</article-id><article-id pub-id-type="publisher-id">262</article-id><article-id pub-id-type="doi">10.1186/s13098-017-0262-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association between aerobic capacity and the improvement in glycemic control after the exercise training in type 2 diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nojima</surname><given-names>Hideki</given-names></name><address><email>hideki_nojima@pearl.ocn.ne.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yoneda</surname><given-names>Masayasu</given-names></name><address><phone>81-82-257-5196</phone><email>masayone17@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Watanabe</surname><given-names>Hiroshi</given-names></name><address><email>drhiroshi@tsuchiya-hp.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Yamane</surname><given-names>Kiminori</given-names></name><address><email>kiminori.yamane.dw@west.ntt.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kitahara</surname><given-names>Yoshihiro</given-names></name><address><email>mayunachinase@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Sekikawa</surname><given-names>Kiyokazu</given-names></name><address><email>sekikawa@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Hideya</given-names></name><address><email>hideyayama@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Yokoyama</surname><given-names>Akihito</given-names></name><address><email>ayokoyama@kochi-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Hattori</surname><given-names>Noboru</given-names></name><address><email>nhattori@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kohno</surname><given-names>Nobuoki</given-names></name><address><email>nokohno@hcu.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><collab>the Hiroshima University Health Promotion Study group<contrib-group><contrib contrib-type="author"><name><surname>Eboshida</surname><given-names>Akira</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hashimoto</surname><given-names>Yasuo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kawasaki</surname><given-names>Hiromi </given-names></name></contrib><contrib contrib-type="author"><name><surname>Kato</surname><given-names>Norihisa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kurihara</surname><given-names>Hidemi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ochi</surname><given-names>Mitsuo </given-names></name></contrib><contrib contrib-type="author"><name><surname>Ohtaki</surname><given-names>Megu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Onari</surname><given-names>Kiyoshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Inamizu</surname><given-names>Tsutomu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Asahara</surname><given-names>Toshimasa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Harada</surname><given-names>Ryozo</given-names></name></contrib></contrib-group></collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution>Department of Molecular and Internal Medicine, Institute of Biomedical &#x00026; Health Sciences, </institution><institution>Hiroshima University, </institution></institution-wrap>1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution>Department of Sports Medicine, </institution><institution>Hiroshima University, </institution></institution-wrap>1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution>Department of Cardiovascular Medicine, </institution><institution>Hiroshima University, </institution></institution-wrap>1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 Japan </aff><aff id="Aff4"><label>4</label>Nojima Internal Medicine Clinic, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 Japan </aff><aff id="Aff5"><label>5</label>Department of Endocrinology, Tsuchiya General Hospital, 3-30 Nakajima-cho, Naka-ku, Hiroshima 730-8655 Japan </aff><aff id="Aff6"><label>6</label>Chugoku Health Administration Center, Nippon Telegraph and Telephone West Corporation, 11-40 Hijiyama-honmachi, Minami-ku, Hiroshima, 732-0816 Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.440118.8</institution-id><institution>Department of Respiratory Medicine, National Hospital Organization, </institution><institution>Kure Medical Center, </institution></institution-wrap>3-1 Aoyama-cho, Kure, 736-0023 Japan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0659 9825</institution-id><institution-id institution-id-type="GRID">grid.278276.e</institution-id><institution>Department of Hematology &#x00026; Respiratory Medicine, </institution><institution>Kochi University, </institution></institution-wrap>Oko-cho Kohasu, Nankoku, Kochi 783-8505 Japan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0405 5965</institution-id><institution-id institution-id-type="GRID">grid.471594.a</institution-id><institution/><institution>Hiroshima Cosmopolitan University, </institution></institution-wrap>Ujina Campus, 5-13-18 Ujinanishi, Minami-ku, Hiroshima, Hiroshima 734-0014 Japan </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>9</volume><elocation-id>63</elocation-id><history><date date-type="received"><day>25</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>9</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">We investigated the influence of aerobic capacity on the improvement in glycemic control achieved by long-term aerobic exercise in type 2 diabetes.</p></sec><sec><title>Methods</title><p id="Par2">Fifty-three male patients with type 2 diabetes, recruited from outpatient clinics, wore multiple-memory accelerometers and were instructed to exercise at moderate intensity for &#x02265;30&#x000a0;min on &#x02265;3&#x000a0;days per week over 12&#x000a0;months. Peak oxygen uptake (peak <inline-formula id="IEq100"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M2"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq100.gif"/></alternatives></inline-formula>) and serum glycated albumin (GA) were measured at baseline and after 3, 6, 12&#x000a0;months. Peak <inline-formula id="IEq101"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq101.gif"/></alternatives></inline-formula> data were expressed as percentages of predicted values.</p></sec><sec><title>Results</title><p id="Par3">According to the number of bouts of exercise (intensity, &#x02265;4 METs; duration, &#x02265;15&#x000a0;min), the subjects were divided into inactive (&#x0003c;3 times per week) or active (&#x02265;3 times per week) groups. Serum GA decreased significantly after 3, 6, 12&#x000a0;months only in the active group. When the subjects were assigned to four groups according to initial peak <inline-formula id="IEq1"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq1.gif"/></alternatives></inline-formula> (%pred) (low-fitness or high-fitness) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3, 6, 12&#x000a0;months only in the high-fitness/active group. When the subjects were also assigned to four groups according to the change in peak <inline-formula id="IEq50"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq50.gif"/></alternatives></inline-formula> (%pred) (improved or unimproved) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3 and 12&#x000a0;months only in the improved/active group.</p></sec><sec><title>Conclusion</title><p id="Par4">The improvement in glycemic control achieved by aerobic exercise was associated with both the initial and the increase in peak <inline-formula id="IEq2"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq2.gif"/></alternatives></inline-formula> during aerobic exercise.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s13098-017-0262-9) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Aerobic exercise training</kwd><kwd>Accelerometer</kwd><kwd>Peak oxygen uptake</kwd><kwd>Type 2 diabetes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par11">Exercise plays a major role in the prevention [<xref ref-type="bibr" rid="CR1">1</xref>] and control [<xref ref-type="bibr" rid="CR2">2</xref>] of type 2 diabetes. Physical activity and aerobic capacity act as independent measures of exercise parameters. Lynch et al. reported that both moderately intense physical activity and high levels of aerobic capacity independently reduced the risk of type 2 diabetes in middle-aged men [<xref ref-type="bibr" rid="CR3">3</xref>]. The Canadian physical activity longitudinal study also found an inverse association between aerobic capacity and the incidence of diabetes independent of the levels of leisure-time physical activity [<xref ref-type="bibr" rid="CR4">4</xref>]. These two reports indicate that physical activity and aerobic capacity are independently associated with the risk of developing type 2 diabetes.</p><p id="Par12">Peak oxygen uptake (peak <inline-formula id="IEq4"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq4.gif"/></alternatives></inline-formula>) is the gold standard measure of aerobic capacity [<xref ref-type="bibr" rid="CR5">5</xref>]. Peak <inline-formula id="IEq5"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq5.gif"/></alternatives></inline-formula> is reduced in type 2 diabetic patients compared with non-diabetic subjects [<xref ref-type="bibr" rid="CR6">6</xref>], and a low peak <inline-formula id="IEq6"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq6.gif"/></alternatives></inline-formula> strongly predicts long-term cardiac mortality in type 2 diabetic patients [<xref ref-type="bibr" rid="CR7">7</xref>]. Seibaek et al. also reported an inverse correlation between insulin resistance and peak <inline-formula id="IEq7"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq7.gif"/></alternatives></inline-formula> in type 2 diabetic patients [<xref ref-type="bibr" rid="CR8">8</xref>]. Furthermore, aerobic exercise significantly increases peak <inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M20"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq8.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR9">9</xref>] and improves glycemic control in type 2 diabetic patients [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Larose et al. reported that improvements in maximal aerobic fitness were significantly related with improvements in HbA1c with aerobic training only and with combined aerobic and resistance training [<xref ref-type="bibr" rid="CR12">12</xref>]. However, the influence of aerobic capacity on the improvement in glycemic control associated with aerobic exercise training in type 2 diabetic patients has yet to be conclusively established.</p><p id="Par13">The Hiroshima University Health Promotion Study was an exercise training study, the main purpose of which was to assess the cardiovascular, metabolic, and hormonal responses to aerobic exercise training in type 2 diabetic patients. We previously reported that moderate-intensity aerobic exercise training over 12&#x000a0;months reduced oxidative stress and improved glycemic control in type 2 diabetic patients [<xref ref-type="bibr" rid="CR13">13</xref>]. In the present study, we instructed patients with type 2 diabetes to perform aerobic exercise training over a 12-month period, and peak <inline-formula id="IEq9"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M22"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq9.gif"/></alternatives></inline-formula> and serum glycated albumin (GA) levels were measured at baseline and after 3, 6, 12&#x000a0;months to determine the effect of aerobic capacity on glycemic control.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Subjects</title><p id="Par14">The study participants consisted of 62 male patients with type 2 diabetes (age range, 35&#x02013;74&#x000a0;years) recruited from outpatient clinics between January and July, 2003, 55 of whom were considered eligible. We collected follow-up data from January, 2003 until August, 2004. Diabetes was defined according to established criteria [<xref ref-type="bibr" rid="CR14">14</xref>]. The exclusion criteria included (1) hemoglobin A1C &#x02265;10% (82.94&#x000a0;mmol/mol), (2) clinical findings of diabetic micro- or macro-vascular complications, (3) taking insulin therapy, (4) inability to walk for exercise, (5) medical conditions potentially contraindicating the exercise program, and (6) obstructive or restrictive abnormalities in spirometry: [forced expiratory volume in one second (FEV<sub>1</sub>)/forced vital capacity (FVC)] &#x0003c;70% or {percent predicted value of FVC [FVC (%pred)]} &#x0003c;80%. Two participants withdraw from the study due to low back pain limiting exercise training (1 patient) and respiratory tract infection (1 patient). The remaining 53 patients were included in analysis.</p></sec><sec id="Sec4"><title>Ethics approval and consent to participate</title><p id="Par15">The study protocol, which is in accordance with the Declaration of Helsinki, was approved by the Ethics Committee of Hiroshima University and written informed consent was obtained from all participants prior to commencement of the study.</p></sec><sec id="Sec5"><title>Clinical examination</title><p id="Par16">Information on the duration of diabetes and smoking status was collected at baseline. Anthropometry (height and body weight), blood pressure measurement, blood sampling and cardiopulmonary exercise testing were performed at baseline and after 3, 6, 12&#x000a0;months of the aerobic training program. Blood pressure were measured using an automatic pulse-wave velocimeter (Form PWV/ABI, model BP-203RPE, Japan Colin Cooperation). Body mass index was calculated by dividing weight (in kilograms) by height (in meters) squared. Total body fat (%) was assessed by bioimpedance measurements (TBF-501; Tanita, Tokyo, Japan). At baseline and after 12&#x000a0;months, a registered dietitian calculated caloric intake using food frequency questionnaire software, Excel Eiyoukun FFQg (v 1.0) (Kenpousha Co. Ltd., Tokyo, Japan). Venous blood samples were taken after meals prior to an exercise test to prevent hypoglycemia during the exercise test. Total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, and HbA1c were measured at the respective outpatient clinics. Serum glycated albumin (GA) was measured by high performance liquid chromatography [<xref ref-type="bibr" rid="CR15">15</xref>]. C-reactive protein (CRP) was measured using latex-enhanced immunonephelometric assays [<xref ref-type="bibr" rid="CR16">16</xref>] on a BNII analyzer (Dade Behring, Tokyo, Japan).</p><p id="Par17">Serum GA was measured to monitor glycemic control. Serum GA levels reflect overall glycemic control during the previous 2&#x000a0;weeks, whereas HbA1c provides an integrated measurement of blood glucose during the previous 2&#x02013;3&#x000a0;months [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Schleicher et al. have proposed that glycated serum protein is a more sensitive index than HbA1c, possibly as a consequence of the higher albumin content in serum [<xref ref-type="bibr" rid="CR19">19</xref>]. Ueda et al. also found that there was greater glucose binding over time in GA than HbA1c for all glucose concentrations [<xref ref-type="bibr" rid="CR20">20</xref>]. Yoshiyuki et al. demonstrated that GA is a better indicator for glucose excursion than HbA1c in type 2 diabetes [<xref ref-type="bibr" rid="CR21">21</xref>]. Therefore, serum GA was used as a sensitive marker of glycemic control because the subjects in this study did not have markedly abnormal glycemic control.</p></sec><sec id="Sec6"><title>Spirometry</title><p id="Par18">FEV<sub>1</sub> and FVC were measured at baseline and after 12&#x000a0;months by an experienced technician using HI-701 (Chest Co., Tokyo, Japan) or SUPER SPIRO DISCOM-21 FX&#x0041f; (Chest Co., Tokyo, Japan), respectively. Spirometric maneuvers were performed according to recommendations of the American Thoracic Society [<xref ref-type="bibr" rid="CR22">22</xref>]. FEV<sub>1</sub> data were reported in the absolute values and represented as FEV<sub>1</sub> (%pred) as calculated by Berglund&#x02019;s equation [<xref ref-type="bibr" rid="CR23">23</xref>]. FVC data were reported in absolute values and expressed as FVC (%pred) as calculated by Baldwin&#x02019;s equation [<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec><sec id="Sec7"><title>Determination of peak oxygen uptake</title><p id="Par19">All participants underwent a cardiopulmonary exercise test using a bicycle ergometer (Ergometer STB-2400: Nihon Kohden Co., Tokyo, Japan). After a sufficient period of rest on the ergometer, exercise was started with a 1-min warm-up at 10&#x000a0;W, followed by the ramp protocol (20&#x000a0;W/min). An electrocardiogram and heart rates were recorded during the test using an electrocardiograph (QP932D: Nihon Kohden Co., Tokyo, Japan). <inline-formula id="IEq10"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq10.gif"/></alternatives></inline-formula> was measured using a respiratory gas-exchange analyzer (AE300SRC: Minato Medical Science Co. Ltd., Osaka, Japan). The exercise test was terminated when any of the following conditions were observed: (1) the subject&#x02019;s predicted maximum heart rate [220&#x02014;age (years)] was achieved, (2) detection of ischemic signs in the electrocardiogram, or (3) the subject could no longer sustain a pedaling cadence of at least 50 revolutions per minute due to dyspnea, leg fatigue, or other symptoms [<xref ref-type="bibr" rid="CR25">25</xref>]. Peak <inline-formula id="IEq11"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq11.gif"/></alternatives></inline-formula> was estimated by extrapolating to the estimated maximal heart rate when heart rate was plotted against <inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M28"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq12.gif"/></alternatives></inline-formula>. Peak <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq13.gif"/></alternatives></inline-formula> data was reported in absolute values and expressed as a percentage of the predicted value [peak <inline-formula id="IEq14"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M32"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq14.gif"/></alternatives></inline-formula> (%pred)]. In this study, the peak <inline-formula id="IEq15"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M34"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq15.gif"/></alternatives></inline-formula> (%pred) was calculated using the formula for Japanese male equation as follows: Peak <inline-formula id="IEq150"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq150.gif"/></alternatives></inline-formula>&#x000a0;=&#x000a0;51.445&#x02212;0.331&#x000a0;&#x000d7;&#x000a0;age (years) [<xref ref-type="bibr" rid="CR26">26</xref>]. We used the percentage of predicted value because we assess the effect of initial peak <inline-formula id="IEq151"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M38"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq151.gif"/></alternatives></inline-formula> on improvements in glycemic control achieved by aerobic exercise training.</p></sec><sec id="Sec8"><title>Exercise training protocol and assessment of physical activity</title><p id="Par20">All participants were requested to perform aerobic exercise for &#x02265;30&#x000a0;min on &#x02265;3&#x000a0;days per week at baseline, with follow-up requests after 3, 6, and 12&#x000a0;months. The American College of Sports Medicine and the American Diabetes Association recommend moderate-to-vigorous intensity aerobic exercise in type 2 diabetic patients [<xref ref-type="bibr" rid="CR27">27</xref>], accordingly our study&#x02019;s exercise intensity was targeted at 50% of peak <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M40"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq16.gif"/></alternatives></inline-formula> using a pulse rate monitor (6102, Tanita, Tokyo, Japan). The recommended types of aerobic exercise were walking and jogging. No specific advice was given to the subjects concerning dietary habits during the study period. All subjects received regular treatment for diabetes mellitus at their outpatient clinics.</p><p id="Par21">To examine the subjects&#x02019; physical activity, pedometers with multiple-memory uniaxial accelerometers (Life Corder; Suzuken Co. Ltd, Nagoya, Japan) were used. This device records the number of footsteps and 10-level exercise intensity every 4&#x000a0;s, based on the amplitude and frequency of accelerations in the vertical direction. The exercise intensity calculated by the device corresponds with daily activities as estimated by a time-motion study, and it also correlates with overall energy expenditure as determined by whole-body indirect calorimetry or breath gas analysis [<xref ref-type="bibr" rid="CR28">28</xref>]. All participants were requested to wear the accelerometer over the right or left hip throughout the day, to follow their usual routine of daily activities and to remove the pedometer only when bathing, showering or sleeping. The data of the accelerometer were retrieved at baseline and after 3, 6, 12&#x000a0;months of the aerobic training program. We used physical activity data every day for statistical analysis.</p><p id="Par22">The duration, frequency, and intensity of physical activity were classified using the pedometers described above. The study subjects were divided into inactive (&#x0003c;3 times per week, n&#x000a0;=&#x000a0;30) and active (&#x02265;3 times per week, n&#x000a0;=&#x000a0;23) groups according to the number of exercise bouts (intensity, &#x02265;4 METs; duration, &#x02265;15&#x000a0;min), as 50% of initial peak <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq17.gif"/></alternatives></inline-formula> was equivalent to 3.7&#x000a0;&#x000b1;&#x000a0;0.7 METs in our study. To assess the effect of initial peak <inline-formula id="IEq18"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M44"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq18.gif"/></alternatives></inline-formula> on improvements in glycemic control achieved by aerobic exercise training, the subjects were also assigned to groups according to peak <inline-formula id="IEq19"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M46"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq19.gif"/></alternatives></inline-formula> (%pred) measured at baseline, including low-fitness [&#x0003c;median peak <inline-formula id="IEq20"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq20.gif"/></alternatives></inline-formula> (%pred) of all subjects: 100.2%] or high-fitness [&#x0003e;median peak <inline-formula id="IEq21"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq21.gif"/></alternatives></inline-formula> (%pred) of all subjects] groups. Furthermore, to determine the effect of the increase in peak oxygen uptake on glycemic control, the study subjects were also divided into unimproved [reduced peak <inline-formula id="IEq22"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M52"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq22.gif"/></alternatives></inline-formula> (%pred) after 12&#x000a0;months] and improved [increased peak <inline-formula id="IEq23"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M54"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq23.gif"/></alternatives></inline-formula> (%pred) after 12&#x000a0;months] groups.</p></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par23">Differences in categorical variables between the groups before intervention were analyzed using the Chi square test, while continuous variables were tested by analysis of covariance&#x000a0;(ANCOVA) adjusted for age, followed by a Bonferroni multiple comparison test. Serum triglyceride level was log-transformed because of a skewed data distribution. Repeated measures ANOVA models were used to analyze, followed by a Bonferroni multiple comparison test. Repeated measures two-way (time&#x000a0;&#x000d7;&#x000a0;group) ANOVA models were used to analyze the effect of intervention on outcome measures to assess the difference between the groups. <italic>P</italic> values of &#x0003c;0.05 were considered to be statistically significant. The statistical tests were performed using the SPSS 12.0 J software program (SPSS Japan, Inc., Tokyo, Japan).</p></sec></sec><sec id="Sec10"><title>Results</title><p id="Par24">The subjects in the active group were significantly older than those in the inactive group, while serum HDL cholesterol level at baseline was significantly higher in the active group than in the inactive group after adjusting for age (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). However, the other baseline characteristics were similar between the two study groups.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Characteristics of the study participants at baseline and exercise volume of the study participants during the study period</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left">Inactive group (n&#x000a0;=&#x000a0;30)</th><th align="left">Active group (n&#x000a0;=&#x000a0;23)</th><th align="left">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">51.9&#x000a0;&#x000b1;&#x000a0;10.1</td><td align="left">57.6&#x000a0;&#x000b1;&#x000a0;7.8</td><td char="." align="char">0.031</td></tr><tr><td align="left">Duration of diabetes (years)</td><td align="left">6.1&#x000a0;&#x000b1;&#x000a0;4.5</td><td align="left">7.7&#x000a0;&#x000b1;&#x000a0;6.3</td><td char="." align="char">0.298</td></tr><tr><td align="left">Smoking status (never/past/current)</td><td align="left">6/14/10</td><td align="left">6/11/6</td><td char="." align="char">0.081</td></tr><tr><td align="left" colspan="4">Diabetes treatment</td></tr><tr><td align="left">&#x000a0;Sulphonylureas</td><td align="left">10</td><td align="left">9</td><td char="." align="char">0.575</td></tr><tr><td align="left">&#x000a0;&#x003b1; glucosidase inhibitors</td><td align="left">9</td><td align="left">7</td><td char="." align="char">0.888</td></tr><tr><td align="left">&#x000a0;Biguanides</td><td align="left">6</td><td align="left">1</td><td char="." align="char">0.107</td></tr><tr><td align="left">&#x000a0;Thiazolidines</td><td align="left">2</td><td align="left">0</td><td char="." align="char">0.217</td></tr><tr><td align="left">&#x000a0;Glinides</td><td align="left">2</td><td align="left">0</td><td char="." align="char">0.217</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">25.9&#x000a0;&#x000b1;&#x000a0;4.4</td><td align="left">23.7&#x000a0;&#x000b1;&#x000a0;3.5</td><td char="." align="char">0.185</td></tr><tr><td align="left">Total body fat (%)</td><td align="left">25.5&#x000a0;&#x000b1;&#x000a0;7.6</td><td align="left">21.9&#x000a0;&#x000b1;&#x000a0;6.2</td><td char="." align="char">0.342</td></tr><tr><td align="left">Lean body mass (kg)</td><td align="left">52.7&#x000a0;&#x000b1;&#x000a0;6.0</td><td align="left">50.0&#x000a0;&#x000b1;&#x000a0;6.4</td><td char="." align="char">0.250</td></tr><tr><td align="left">Systolic blood pressure (mmHg)</td><td align="left">139.2&#x000a0;&#x000b1;&#x000a0;16.9</td><td align="left">140.2&#x000a0;&#x000b1;&#x000a0;21.2</td><td char="." align="char">0.942</td></tr><tr><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">85.6&#x000a0;&#x000b1;&#x000a0;9.5</td><td align="left">84.1&#x000a0;&#x000b1;&#x000a0;11.3</td><td char="." align="char">0.707</td></tr><tr><td align="left">Total cholesterol (mmol/l)</td><td align="left">5.31&#x000a0;&#x000b1;&#x000a0;0.85</td><td align="left">5.32&#x000a0;&#x000b1;&#x000a0;0.97</td><td char="." align="char">0.509</td></tr><tr><td align="left">Triglyceride<sup>a</sup> (mmol/l)</td><td align="left">1.51 (1.04&#x02013;2.32)</td><td align="left">1.46 (0.88&#x02013;1.90)</td><td char="." align="char">0.958</td></tr><tr><td align="left">HDL cholesterol (mmol/l)</td><td align="left">1.23&#x000a0;&#x000b1;&#x000a0;0.25</td><td align="left">1.46&#x000a0;&#x000b1;&#x000a0;0.33</td><td char="." align="char">0.022</td></tr><tr><td align="left">HbA1c (%)</td><td align="left">7.5&#x000a0;&#x000b1;&#x000a0;1.3</td><td align="left">7.5&#x000a0;&#x000b1;&#x000a0;1.0</td><td char="." align="char">0.700</td></tr><tr><td align="left">Glycated albumin (%)</td><td align="left">21.7&#x000a0;&#x000b1;&#x000a0;4.8</td><td align="left">23.5&#x000a0;&#x000b1;&#x000a0;4.0</td><td char="." align="char">0.256</td></tr><tr><td align="left">Peak <inline-formula id="IEq41"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq41.gif"/></alternatives></inline-formula> (ml/min/kg)</td><td align="left">25.6&#x000a0;&#x000b1;&#x000a0;5.2</td><td align="left">27.0&#x000a0;&#x000b1;&#x000a0;4.1</td><td char="." align="char">0.057</td></tr><tr><td align="left">Peak <inline-formula id="IEq410"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq410.gif"/></alternatives></inline-formula> (%pred) (%)</td><td align="left">97.3&#x000a0;&#x000b1;&#x000a0;18.9</td><td align="left">106.9&#x000a0;&#x000b1;&#x000a0;15.1</td><td char="." align="char">0.052</td></tr><tr><td align="left">FVC (%pred) (%)</td><td align="left">110.5&#x000a0;&#x000b1;&#x000a0;13.4</td><td align="left">106.0&#x000a0;&#x000b1;&#x000a0;12.8</td><td char="." align="char">0.366</td></tr><tr><td align="left">FEV<sub>1</sub> (%pred) (%)</td><td align="left">105.3&#x000a0;&#x000b1;&#x000a0;13.2</td><td align="left">107.8&#x000a0;&#x000b1;&#x000a0;14.3</td><td char="." align="char">0.766</td></tr><tr><td align="left">FEV<sub>1</sub>/FVC (%)</td><td align="left">78.8&#x000a0;&#x000b1;&#x000a0;4.9</td><td align="left">78.9&#x000a0;&#x000b1;&#x000a0;4.2</td><td char="." align="char">0.369</td></tr><tr><td align="left">Number of steps (/day)</td><td align="left">6477&#x000a0;&#x000b1;&#x000a0;2586</td><td align="left">11,690&#x000a0;&#x000b1;&#x000a0;4842</td><td char="." align="char">&#x0003c;0.001</td></tr><tr><td align="left">Number of exercise bouts (/week)</td><td align="left">0.9&#x000a0;&#x000b1;&#x000a0;0.8</td><td align="left">8.8&#x000a0;&#x000b1;&#x000a0;6.6</td><td char="." align="char">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><p>Results were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD or median (interquartile range)</p><p>Values were analyzed by analysis of covariance (ANCOVA) with age as the covariate</p><p>
<sup>a</sup>Analyses performed on the natural logarithm</p></table-wrap-foot></table-wrap>
</p><p id="Par25">Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows that serum GA levels decreased significantly after 3, 6, 12&#x000a0;months in the active group, whereas no significant change was observed in the inactive group. Peak <inline-formula id="IEq24"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M60"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq24.gif"/></alternatives></inline-formula> (%pred) increased after 12&#x000a0;months in the active group, but remained unchanged in the inactive group. There was no significant change in the caloric intake during the study period in any group (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Effect of aerobic exercise on glycemic control and peak <inline-formula id="IEq36"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M62"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq36.gif"/></alternatives></inline-formula>. <bold>a</bold>, <bold>c</bold> The inactive groups; <bold>b</bold>, <bold>d</bold> the inactive groups. The results are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 vs. baseline. Inactive group (n&#x000a0;=&#x000a0;30), active group (n&#x000a0;=&#x000a0;23) <italic>GA</italic> glycated albumin, <italic>N.S.</italic> not significant</p></caption><graphic xlink:href="13098_2017_262_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par26">Subsequently, the subjects were subdivided into low-fitness/inactive (n&#x000a0;=&#x000a0;19), low-fitness/active (n&#x000a0;=&#x000a0;7), high-fitness/inactive (n&#x000a0;=&#x000a0;11), and high-fitness/active groups (n&#x000a0;=&#x000a0;16). The baseline characteristics of the study subjects are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2. Although the systolic blood pressure was significantly higher in the low-fitness/active group compared with the high-fitness/active group (<italic>P</italic>&#x000a0;=&#x000a0;0.035), the other baseline characteristics did not differ among the four study groups. Serum GA levels significantly decreased after 3, 6, 12&#x000a0;months only in the high-fitness/active group, whereas they remained unchanged in the other three groups (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Analysis by repeated measures two-way ANOVA model showed that there was no intergroup difference in the change in GA levels (P&#x000a0;=&#x000a0;0.599). Peak <inline-formula id="IEq25"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M64"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq25.gif"/></alternatives></inline-formula> (%pred) showed a trend to increase in the low-fitness/active group (<italic>P</italic>&#x000a0;=&#x000a0;0.085) but did not change in the other three groups (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Serum CRP levels significantly increased after 3, 6, 12&#x000a0;months only in the high-fitness/inactive group, whereas they remained unchanged in the other three groups (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Effect of initial peak <inline-formula id="IEq37"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M66"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq37.gif"/></alternatives></inline-formula> on change in glycemic control resulting from aerobic exercise. <bold>a</bold> Low-fitness/inactive group (n&#x000a0;=&#x000a0;19), <bold>b</bold> low-fitness/active group (n&#x000a0;=&#x000a0;7), <bold>c</bold> high-fitness/inactive group (n&#x000a0;=&#x000a0;11), <bold>d</bold> high-fitness/active group (n&#x000a0;=&#x000a0;16). The results are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 vs. baseline. <italic>GA</italic> glycated albumin, <italic>N.S</italic>. not significant</p></caption><graphic xlink:href="13098_2017_262_Fig2_HTML" id="MO2"/></fig>
<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Effect of initial peak <inline-formula id="IEq38"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M68"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq38.gif"/></alternatives></inline-formula> on change in peak <inline-formula id="IEq39"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M70"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq39.gif"/></alternatives></inline-formula> resulting from aerobic exercise. <bold>a</bold> Low-fitness/inactive group (n&#x000a0;=&#x000a0;19), <bold>b</bold> low-fitness/active group (n&#x000a0;=&#x000a0;7), <bold>c</bold> high-fitness/inactive group (n&#x000a0;=&#x000a0;11), <bold>d</bold> high-fitness/active group (n&#x000a0;=&#x000a0;16). The results are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 vs. baseline. <italic>N.S.</italic> not significant</p></caption><graphic xlink:href="13098_2017_262_Fig3_HTML" id="MO3"/></fig>
</p><p id="Par27">Furthermore, the subjects were subdivided into unimproved/inactive (n&#x000a0;=&#x000a0;13), unimproved/active (n&#x000a0;=&#x000a0;8), improved/inactive (n&#x000a0;=&#x000a0;17), and improved/active groups (n&#x000a0;=&#x000a0;15). Baseline HDL cholesterol level was significantly higher in the improved/active compared with the improved/inactive group (<italic>P</italic>&#x000a0;=&#x000a0;0.039), while the other baseline characteristics did not differ among the four groups (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S4). Serum GA levels decreased significantly after 3 and 12&#x000a0;months only in the improved/active group, whereas they did not change in the other three groups (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Analysis by repeated measures two-way ANOVA model showed that there was no intergroup difference in the change in GA levels (P&#x000a0;=&#x000a0;0.669).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Effect of increase in peak <inline-formula id="IEq40"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M72"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq40.gif"/></alternatives></inline-formula> on change in glycemic control resulting from aerobic exercise. <bold>a</bold> Unimproved/inactive group (n&#x000a0;=&#x000a0;13), <bold>b</bold> unimproved/active group (n&#x000a0;=&#x000a0;8), <bold>c</bold> improved/inactive group (n&#x000a0;=&#x000a0;17), <bold>d</bold> improved/active group (n&#x000a0;=&#x000a0;15). The results are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 vs. baseline. <italic>GA</italic> glycated albumin, <italic>N.S.</italic> not significant</p></caption><graphic xlink:href="13098_2017_262_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec11"><title>Discussion</title><p id="Par28">The present study is quite unique in that the initial peak <inline-formula id="IEq26"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M74"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq26.gif"/></alternatives></inline-formula> was a major factor for the improvement in glycemic control achieved by &#x02265;3 aerobic exercise bouts per week in male type 2 diabetic patients. Furthermore, the increase in peak <inline-formula id="IEq27"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M76"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq27.gif"/></alternatives></inline-formula> brought about by long-term aerobic exercise training was associated with the improvement in glycemic control only in the improved/active group.</p><p id="Par29">After 3, 6, 12&#x000a0;months of exercise training, a significant improvement in glycemic control was observed only in subjects categorized as the high-fitness/active group. This suggests that high baseline peak <inline-formula id="IEq28"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq28.gif"/></alternatives></inline-formula>, in addition to aerobic exercise training, is important for improving glycemic control. Previous studies have shown a close relationship between aerobic capacity and incidence of type 2 diabetes, independent of physical activity levels [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. In contrast, the present study demonstrated the degree of aerobic capacity affected the changes in glycemic control associated with aerobic exercise training in type 2 diabetic patients. Oxygen is taken into the lung by respiration and transported to working muscles to be utilized during aerobic exercise [<xref ref-type="bibr" rid="CR29">29</xref>]. A sufficient oxygen uptake is required to aerobically convert glucose into energy during aerobic exercise. The fact may explain the association between initial peak <inline-formula id="IEq29"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M80"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq29.gif"/></alternatives></inline-formula> and the improvement of glycemic control achieved by aerobic exercise training, but the mechanism could not be fully elucidated.</p><p id="Par30">The present study did not show any change in glycemic control in the subjects categorized to the low-fitness/active group. The effect of accumulated short exercise bouts, consisting of more than three bouts of &#x02265;15&#x000a0;min duration of intermediate- or high-intensity aerobic exercise each week, was evaluated. The numbers of steps per day and number of exercise bouts (intensity, &#x02265;4 METs; duration, &#x02265;15&#x000a0;min) per week were similar between the low-fitness/active group and the high-fitness/active group (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The low-fitness male type 2 diabetic patients might thus require more bouts, a longer duration or higher intensity of aerobic exercise to trigger the cascade of mitochondrial genesis and improve glycemic control than that used in this study.</p><p id="Par31">Furthermore, this study found a significant improvement in glycemic control after 12&#x000a0;months of exercise training only in subjects assigned to the improved/active group. This indicates that an increase in peak <inline-formula id="IEq30"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M82"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq30.gif"/></alternatives></inline-formula> following aerobic exercise training is an important factor contributing to the improvement of glycemic control in type 2 diabetic patients. McMurray et al. reported that increased aerobic capacity after a 9-week course of aerobic exercise training was associated with a reduction in cardiovascular risk factors, including hypercholesterolemia and hypertension [<xref ref-type="bibr" rid="CR30">30</xref>]. The current study demonstrated that increased peak <inline-formula id="IEq31"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M84"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq31.gif"/></alternatives></inline-formula> is also important for improving hyperglycemia, one of the cardiovascular risk factors.</p><p id="Par32">Several potential mechanisms may be involved in the beneficial effect of increased peak <inline-formula id="IEq32"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M86"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq32.gif"/></alternatives></inline-formula> on glycemic control. Previous studies have shown that skeletal muscle characteristics such as decreased proportion of type I muscle fibers and capillary density [<xref ref-type="bibr" rid="CR31">31</xref>], increased muscle lipid content [<xref ref-type="bibr" rid="CR32">32</xref>], and a higher glycolytic to oxidative enzyme ratio [<xref ref-type="bibr" rid="CR33">33</xref>] may be associated with decreased insulin sensitivity. These abnormalities potentially contribute to the lower peak <inline-formula id="IEq33"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M88"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq33.gif"/></alternatives></inline-formula> values often seen in type 2 diabetic patients. Moreover, there is evidence that aerobic exercise training increases skeletal muscle capillary density, thereby improving oxidative capacity in these muscles [<xref ref-type="bibr" rid="CR34">34</xref>]. This suggests that aerobic exercise training increases oxygen uptake and enhances oxygen utilization at the level of skeletal muscle, thus increasing skeletal muscle oxidative capacity and, ultimately, increasing insulin sensitivity and improving glycemic control.</p><p id="Par33">There are some limitations of the present study. First, sample size was relatively small, especially the low fitness/active group. Therefore significant improvement in GA could not have been observed in the low fitness/active group. Second, exercise training in this study was not performed under the supervision of a trained investigator, and this study may be considered as assessing the effects of exercise in a naturalistic environment. In this study, the subjects&#x02019; actual physical activity was quantified over a 12-month period using pedometers with multiple-memory uniaxial accelerometers, and we investigated the long-term efficacy of short bouts of aerobic exercise for &#x02265;15&#x000a0;min per bout at least 3 times a week over a 12-month period in type 2 diabetic patients.</p></sec><sec id="Sec12"><title>Conclusions</title><p id="Par34">The initial peak <inline-formula id="IEq34"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq34.gif"/></alternatives></inline-formula> and the increase in peak <inline-formula id="IEq35"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M92"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq35.gif"/></alternatives></inline-formula> achieved by our study&#x02019;s aerobic exercise training protocol could be an important role in the improvement of glycemic control in male type 2 diabetic patients. Furthermore, short bouts of exercise could enhance aerobic capacity and improve glycemic control in type 2 diabetes with long-term aerobic exercise training. Further studies are needed to elucidate the association between aerobic capacity and the improvement in glycemic control after the exercise training in type 2 diabetes because analysis by repeated measures two-way ANOVA model showed that there was no intergroup difference in the change in GA levels in our study.</p></sec></body><back><app-group><app id="App1"><sec id="Sec13"><title>Additional file</title><p>
<media position="anchor" xlink:href="13098_2017_262_MOESM1_ESM.docx" id="MOESM1"><caption><p>
<bold>Additional file 1: Table S1.</bold> Caloric intake of the study participants during the study period. <bold>Table S2.</bold> Characteristics of the study subjects at baseline and exercise volume of the study participants during the study period. <bold>Table S3.</bold> CRP of the study participants during the study period. <bold>Table S4.</bold> Characteristics of the study subjects at baseline and exercise volume of the study participants during the study period.</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>CRP</term><def><p id="Par5">C-reactive protein</p></def></def-item><def-item><term>FEV<sub>1</sub></term><def><p id="Par6">forced expiratory volume in one second</p></def></def-item><def-item><term>FVC</term><def><p id="Par7">forced vital capacity</p></def></def-item><def-item><term>HDL cholesterol</term><def><p id="Par8">high-density lipoprotein cholesterol</p></def></def-item><def-item><term>GA</term><def><p id="Par9">glycated albumin</p></def></def-item><def-item><term>peak <inline-formula id="IEq3"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\dot{\text{V}}\text{O}}_{ 2}$$\end{document}</tex-math><mml:math id="M94"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mtext>V</mml:mtext><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mtext>O</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13098_2017_262_Article_IEq3.gif"/></alternatives></inline-formula></term><def><p id="Par10">peak oxygen uptake</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1186/s13098-017-0262-9) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Authors&#x02019; contributions</title><p>HN drafted the manuscript, performed the statistical analysis and organized the study. MY, AY, and NH contributed to the writing of the manuscript. HW and KY participated in its design and coordination helped to draft the manuscript. NK participated in its design, revision of the article and supervision of the study. YK conducted the spirometry. KS and HY underwent the cardiopulmonary exercise test. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p id="Par35">The Hiroshima University Health Promotion Study was undertaken by Hiroshima University in co-operation with the Corporations of Hiroshima Prefecture, Hiroshima City, and Higashi-Hiroshima City. This work was also a special enterprise for social contribution supported by the Ministry of Education, Culture, Sports, Science, and Technology. We wish to thank Rie Shimooka, Department of Nutrition and Health Promotion, Faculty of Human Life Science, Hiroshima Jogakuin University for dietary assessments in the study.</p><p id="Par36">
<bold>Committee members of the Hiroshima University Health Promotion Study group</bold>
</p><p id="Par37">Akira Eboshida, Yasuo Hashimoto, Hiromi Kawasaki, Norihisa Kato, Hidemi Kurihara, Mitsuo Ochi, Megu Ohtaki, Kiyoshi Onari, Tsutomu Inamizu, Toshimasa Asahara (Hiroshima University); Ryozo Harada (Hiroshima University High School).</p></sec><sec id="FPar2"><title>Competing interests</title><p id="Par38">The authors declare that they have no competing interests.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par39">The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></sec><sec id="FPar4"><title>Funding</title><p id="Par40">The authors received no specific funding for this article.</p></sec><sec id="FPar5"><title>Publisher&#x02019;s Note</title><p id="Par41">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>CY</given-names></name><name><surname>Lokken</surname><given-names>RP</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>van Dam</surname><given-names>RM</given-names></name></person-group><article-title>Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><issue>3</issue><fpage>744</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.2337/dc06-1842</pub-id><pub-id pub-id-type="pmid">17327354</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Ribeiro</surname><given-names>PA</given-names></name><name><surname>Kramer</surname><given-names>CK</given-names></name><name><surname>Leitao</surname><given-names>CB</given-names></name><name><surname>Zucatti</surname><given-names>AT</given-names></name><name><surname>Azevedo</surname><given-names>MJ</given-names></name><name><surname>Gross</surname><given-names>JL</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name></person-group><article-title>Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis</article-title><source>JAMA</source><year>2011</year><volume>305</volume><issue>17</issue><fpage>1790</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.576</pub-id><pub-id pub-id-type="pmid">21540423</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>J</given-names></name><name><surname>Helmrich</surname><given-names>SP</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Kaplan</surname><given-names>GA</given-names></name><name><surname>Cohen</surname><given-names>RD</given-names></name><name><surname>Salonen</surname><given-names>R</given-names></name><name><surname>Salonen</surname><given-names>JT</given-names></name></person-group><article-title>Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men</article-title><source>Arch Intern Med</source><year>1996</year><volume>156</volume><issue>12</issue><fpage>1307</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1001/archinte.1996.00440110073010</pub-id><pub-id pub-id-type="pmid">8651839</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name><name><surname>Craig</surname><given-names>CL</given-names></name><name><surname>Gauvin</surname><given-names>L</given-names></name></person-group><article-title>Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><issue>3</issue><fpage>538</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1007/s00125-006-0554-3</pub-id><pub-id pub-id-type="pmid">17221212</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>GF</given-names></name><name><surname>Balady</surname><given-names>GJ</given-names></name><name><surname>Amsterdam</surname><given-names>EA</given-names></name><name><surname>Chaitman</surname><given-names>B</given-names></name><name><surname>Eckel</surname><given-names>R</given-names></name><name><surname>Fleg</surname><given-names>J</given-names></name><name><surname>Froelicher</surname><given-names>VF</given-names></name><name><surname>Leon</surname><given-names>AS</given-names></name><name><surname>Pina</surname><given-names>IL</given-names></name><name><surname>Rodney</surname><given-names>R</given-names></name><etal/></person-group><article-title>Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association</article-title><source>Circulation</source><year>2001</year><volume>104</volume><issue>14</issue><fpage>1694</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1161/hc3901.095960</pub-id><pub-id pub-id-type="pmid">11581152</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>SH</given-names></name><name><surname>Amorosa</surname><given-names>LF</given-names></name><name><surname>Khachadurian</surname><given-names>AK</given-names></name><name><surname>Ruderman</surname><given-names>NB</given-names></name></person-group><article-title>Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes</article-title><source>Diabetologia</source><year>1984</year><volume>26</volume><issue>5</issue><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1007/BF00266036</pub-id><pub-id pub-id-type="pmid">6376244</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohl</surname><given-names>HW</given-names></name><name><surname>Gordon</surname><given-names>NF</given-names></name><name><surname>Villegas</surname><given-names>JA</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name></person-group><article-title>Cardiorespiratory fitness, glycemic status, and mortality risk in men</article-title><source>Diabetes Care</source><year>1992</year><volume>15</volume><issue>2</issue><fpage>184</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.2337/diacare.15.2.184</pub-id><pub-id pub-id-type="pmid">1547675</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibaek</surname><given-names>M</given-names></name><name><surname>Vestergaard</surname><given-names>H</given-names></name><name><surname>Burchardt</surname><given-names>H</given-names></name><name><surname>Sloth</surname><given-names>C</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Nielsen</surname><given-names>SL</given-names></name><name><surname>Hildebrandt</surname><given-names>P</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name></person-group><article-title>Insulin resistance and maximal oxygen uptake</article-title><source>Clin Cardiol</source><year>2003</year><volume>26</volume><issue>11</issue><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1002/clc.4960261107</pub-id><pub-id pub-id-type="pmid">14640466</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>NG</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name></person-group><article-title>Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus</article-title><source>Diabetologia</source><year>2003</year><volume>46</volume><issue>8</issue><fpage>1071</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1007/s00125-003-1160-2</pub-id><pub-id pub-id-type="pmid">12856082</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>A</given-names></name><name><surname>Franz</surname><given-names>M</given-names></name><name><surname>Hornsby</surname><given-names>G</given-names></name><name><surname>Kriska</surname><given-names>A</given-names></name><name><surname>Marrero</surname><given-names>D</given-names></name><name><surname>Ullrich</surname><given-names>I</given-names></name><name><surname>Verity</surname><given-names>LS</given-names></name></person-group><article-title>American College of Sports Medicine position stand. Exercise and type 2 diabetes</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>32</volume><issue>7</issue><fpage>1345</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1097/00005768-200007000-00024</pub-id><pub-id pub-id-type="pmid">10912903</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wasserman</surname><given-names>DH</given-names></name><name><surname>Castaneda-Sceppa</surname><given-names>C</given-names></name><name><surname>White</surname><given-names>RD</given-names></name></person-group><article-title>Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><issue>6</issue><fpage>1433</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.2337/dc06-9910</pub-id><pub-id pub-id-type="pmid">16732040</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larose</surname><given-names>J</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Khandwala</surname><given-names>F</given-names></name><name><surname>Prud&#x02019;homme</surname><given-names>D</given-names></name><name><surname>Boule</surname><given-names>NG</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name></person-group><article-title>Associations between physical fitness and HbA1c in type 2 diabetes mellitus</article-title><source>Diabetologia</source><year>2011</year><volume>54</volume><issue>1</issue><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1007/s00125-010-1941-3</pub-id><pub-id pub-id-type="pmid">20953579</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Kitahara</surname><given-names>Y</given-names></name><name><surname>Sekikawa</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Yokoyama</surname><given-names>A</given-names></name><name><surname>Inamizu</surname><given-names>T</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Kohno</surname><given-names>N</given-names></name></person-group><article-title>Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus</article-title><source>Metabolism</source><year>2008</year><volume>57</volume><issue>2</issue><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2007.08.021</pub-id><pub-id pub-id-type="pmid">18191045</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>American Diabetes Association clinical practice recommendations 2002</article-title><source>Diabetes Care</source><year>2002</year><volume>25</volume><issue>Suppl 1</issue><fpage>S1</fpage><lpage>S147</lpage><pub-id pub-id-type="pmid">11788484</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>N</given-names></name><name><surname>Abe</surname><given-names>F</given-names></name><name><surname>Hirota</surname><given-names>M</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Uchida</surname><given-names>T</given-names></name><name><surname>Noguchi</surname><given-names>K</given-names></name></person-group><article-title>High-performance liquid chromatographic assay of serum glycated albumin</article-title><source>Diabetologia</source><year>1988</year><volume>31</volume><issue>8</issue><fpage>627</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1007/BF00264772</pub-id><pub-id pub-id-type="pmid">3220198</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>Clinical efficacy of an automated high-sensitivity C-reactive protein assay</article-title><source>Clin Chem</source><year>1999</year><volume>45</volume><issue>12</issue><fpage>2136</fpage><lpage>2141</lpage><pub-id pub-id-type="pmid">10585345</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunn</surname><given-names>HF</given-names></name><name><surname>Gabbay</surname><given-names>KH</given-names></name><name><surname>Gallop</surname><given-names>PM</given-names></name></person-group><article-title>The glycosylation of hemoglobin: relevance to diabetes mellitus</article-title><source>Science</source><year>1978</year><volume>200</volume><issue>4337</issue><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1126/science.635569</pub-id><pub-id pub-id-type="pmid">635569</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>RJ</given-names></name><name><surname>Peterson</surname><given-names>CM</given-names></name><name><surname>Jones</surname><given-names>RL</given-names></name><name><surname>Saudek</surname><given-names>C</given-names></name><name><surname>Lehrman</surname><given-names>M</given-names></name><name><surname>Cerami</surname><given-names>A</given-names></name></person-group><article-title>Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus</article-title><source>N Engl J Med</source><year>1976</year><volume>295</volume><issue>8</issue><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1056/NEJM197608192950804</pub-id><pub-id pub-id-type="pmid">934240</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleicher</surname><given-names>ED</given-names></name><name><surname>Gerbitz</surname><given-names>KD</given-names></name><name><surname>Dolhofer</surname><given-names>R</given-names></name><name><surname>Reindl</surname><given-names>E</given-names></name><name><surname>Wieland</surname><given-names>OH</given-names></name><name><surname>Edelmann</surname><given-names>E</given-names></name><name><surname>Haslbeck</surname><given-names>M</given-names></name><name><surname>Kemmler</surname><given-names>W</given-names></name><name><surname>Walter</surname><given-names>H</given-names></name><name><surname>Mehnert</surname><given-names>H</given-names></name></person-group><article-title>Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control</article-title><source>Diabetes Care</source><year>1984</year><volume>7</volume><issue>6</issue><fpage>548</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.2337/diacare.7.6.548</pub-id><pub-id pub-id-type="pmid">6510180</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>H</given-names></name></person-group><article-title>Recent topics in chemical and clinical research on glycated albumin</article-title><source>J Diabetes Sci Technol</source><year>2015</year><volume>9</volume><issue>2</issue><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1177/1932296814567225</pub-id><pub-id pub-id-type="pmid">25614014</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshiuchi</surname><given-names>K</given-names></name><name><surname>Matsuhisa</surname><given-names>M</given-names></name><name><surname>Katakami</surname><given-names>N</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Umayahara</surname><given-names>Y</given-names></name><name><surname>Kosugi</surname><given-names>K</given-names></name><name><surname>Kaneto</surname><given-names>H</given-names></name><name><surname>Yamasaki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes</article-title><source>Endocr J</source><year>2008</year><volume>55</volume><issue>3</issue><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1507/endocrj.K07E-089</pub-id><pub-id pub-id-type="pmid">18445997</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society</collab></person-group><article-title>Standardization of spirometry, 1994 Update</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>3</issue><fpage>1107</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.152.3.7663792</pub-id><pub-id pub-id-type="pmid">7663792</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>E</given-names></name><name><surname>Birath</surname><given-names>G</given-names></name><name><surname>Bjure</surname><given-names>J</given-names></name><name><surname>Grimby</surname><given-names>G</given-names></name><name><surname>Kjellmer</surname><given-names>I</given-names></name><name><surname>Sandqvist</surname><given-names>L</given-names></name><name><surname>Soderholm</surname><given-names>B</given-names></name></person-group><article-title>Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70&#x000a0;years of age</article-title><source>Acta Med Scand</source><year>1963</year><volume>173</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1111/j.0954-6820.1963.tb16520.x</pub-id><pub-id pub-id-type="pmid">13970718</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>ED</given-names></name><name><surname>Cournaud</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>DW</given-names><suffix>Jr</suffix></name></person-group><article-title>Pulmonary insufficiency physiological classification clinical methods of analysis standard values in normal subjects</article-title><source>Medicine</source><year>1948</year><volume>27</volume><fpage>243</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1097/00005792-194809000-00001</pub-id><pub-id pub-id-type="pmid">18885031</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society/American College of Chest Physicians</collab></person-group><article-title>American Thoracic Society/American College of Chest Physicians Statement on cardiopulmonary exercise testing</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><issue>2</issue><fpage>211</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1164/rccm.167.2.211</pub-id><pub-id pub-id-type="pmid">12524257</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Yamaji K. Kaitei Saidai Sanso Sesshuryou No Kagaku. Kyourin Shoin; 2001. p. 176&#x02013;84 <bold>(in Japanese)</bold>.</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colberg</surname><given-names>SR</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Fernhall</surname><given-names>B</given-names></name><name><surname>Regensteiner</surname><given-names>JG</given-names></name><name><surname>Blissmer</surname><given-names>BJ</given-names></name><name><surname>Rubin</surname><given-names>RR</given-names></name><name><surname>Chasan-Taber</surname><given-names>L</given-names></name><name><surname>Albright</surname><given-names>AL</given-names></name><name><surname>Braun</surname><given-names>B</given-names></name></person-group><article-title>Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>12</issue><fpage>2692</fpage><lpage>2696</lpage><pub-id pub-id-type="doi">10.2337/dc10-1548</pub-id><pub-id pub-id-type="pmid">21115771</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumahara</surname><given-names>H</given-names></name><name><surname>Schutz</surname><given-names>Y</given-names></name><name><surname>Ayabe</surname><given-names>M</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name><name><surname>Yoshitake</surname><given-names>Y</given-names></name><name><surname>Shindo</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry</article-title><source>Br J Nutr</source><year>2004</year><volume>91</volume><issue>2</issue><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1079/BJN20031033</pub-id><pub-id pub-id-type="pmid">14756909</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bacharach</surname><given-names>DW</given-names></name></person-group><person-group person-group-type="editor"><name><surname>LeMura</surname><given-names>LM</given-names></name><name><surname>Von Duvillard</surname><given-names>SP</given-names></name></person-group><article-title>Review of exercise physiology</article-title><source>Clinical exercise physiology</source><year>2004</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><fpage>3</fpage><lpage>13</lpage></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>RG</given-names></name><name><surname>Ainsworth</surname><given-names>BE</given-names></name><name><surname>Harrell</surname><given-names>JS</given-names></name><name><surname>Griggs</surname><given-names>TR</given-names></name><name><surname>Williams</surname><given-names>OD</given-names></name></person-group><article-title>Is physical activity or aerobic power more influential on reducing cardiovascular disease risk factors?</article-title><source>Med Sci Sports Exerc</source><year>1998</year><volume>30</volume><issue>10</issue><fpage>1521</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1097/00005768-199810000-00009</pub-id><pub-id pub-id-type="pmid">9789853</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lillioja</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>AA</given-names></name><name><surname>Culter</surname><given-names>CL</given-names></name><name><surname>Ivy</surname><given-names>JL</given-names></name><name><surname>Abbott</surname><given-names>WG</given-names></name><name><surname>Zawadzki</surname><given-names>JK</given-names></name><name><surname>Yki-Jarvinen</surname><given-names>H</given-names></name><name><surname>Christin</surname><given-names>L</given-names></name><name><surname>Secomb</surname><given-names>TW</given-names></name><name><surname>Bogardus</surname><given-names>C</given-names></name></person-group><article-title>Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man</article-title><source>J Clin Investig</source><year>1987</year><volume>80</volume><issue>2</issue><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1172/JCI113088</pub-id><pub-id pub-id-type="pmid">3301899</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group><article-title>Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><issue>4</issue><fpage>817</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.4.817</pub-id><pub-id pub-id-type="pmid">11289047</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoneau</surname><given-names>JA</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group><article-title>Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM</article-title><source>J Appl Physiol</source><year>1997</year><volume>83</volume><issue>1</issue><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">9216960</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allenberg</surname><given-names>K</given-names></name><name><surname>Johansen</surname><given-names>K</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name></person-group><article-title>Skeletal muscle adaptations to physical training in type II (non-insulin-dependent) diabetes mellitus</article-title><source>Acta Med Scand</source><year>1988</year><volume>223</volume><issue>4</issue><fpage>365</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1111/j.0954-6820.1988.tb15886.x</pub-id><pub-id pub-id-type="pmid">3369317</pub-id></element-citation></ref></ref-list></back></article>